Kichina J, Maslov A, Kandel E
Cells. 2023; 12(19).
PMID: 37830586
PMC: 10572217.
DOI: 10.3390/cells12192373.
Drobiova H, Sindhu S, Ahmad R, Haddad D, Al-Mulla F, Madhoun A
Front Cell Dev Biol. 2023; 11:1211217.
PMID: 37440921
PMC: 10333601.
DOI: 10.3389/fcell.2023.1211217.
Piechowska A, Kruszniewska-Rajs C, Kimsa-Dudek M, Kolomanska M, Strzalka-Mrozik B, Gola J
J Cancer Res Clin Oncol. 2022; 148(7):1569-1582.
PMID: 35292840
DOI: 10.1007/s00432-022-03977-4.
Kukreja L, Li C, Ezhilan S, Iyer V, Kuo J
Neuromolecular Med. 2021; 24(1):41-49.
PMID: 34677796
DOI: 10.1007/s12017-021-08691-x.
Ullah I, Zhao L, Hai Y, Fahim M, Alwayli D, Wang X
Toxicol Rep. 2021; 8:607-616.
PMID: 33816123
PMC: 8010213.
DOI: 10.1016/j.toxrep.2021.03.009.
miR‑182‑5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression.
He W, Jin H, Liu Q, Sun Q
Mol Med Rep. 2020; 23(2).
PMID: 33313953
PMC: 7751459.
DOI: 10.3892/mmr.2020.11769.
Prognostic value of microRNA-20b expression level in patients with prostate cancer.
Zhang R, Li F, Wang Y, Yao M, Chi C
Histol Histopathol. 2020; 35(8):827-831.
PMID: 32286677
DOI: 10.14670/HH-18-216.
miR-590-3p and Its Downstream Target Genes in HCC Cell Lines.
Elfar M, Amleh A
Anal Cell Pathol (Amst). 2019; 2019:3234812.
PMID: 31781476
PMC: 6875279.
DOI: 10.1155/2019/3234812.
miR‑195 suppresses metastasis and angiogenesis of squamous cell lung cancer by inhibiting the expression of VEGF.
Liu H, Chen Y, Li Y, Li C, Qin T, Bai M
Mol Med Rep. 2019; 20(3):2625-2632.
PMID: 31322197
PMC: 6691228.
DOI: 10.3892/mmr.2019.10496.
MicroRNA expression profiling of lung adenocarcinoma in Xuanwei, China: A preliminary study.
Hu Z, Wang X, Yang Y, Zhao Y, Shen Z, Huang Y
Medicine (Baltimore). 2019; 98(21):e15717.
PMID: 31124951
PMC: 6571392.
DOI: 10.1097/MD.0000000000015717.
The TGFβ-signaling pathway and colorectal cancer: associations between dysregulated genes and miRNAs.
Pellatt A, Mullany L, Herrick J, Sakoda L, Wolff R, Samowitz W
J Transl Med. 2018; 16(1):191.
PMID: 29986714
PMC: 6038278.
DOI: 10.1186/s12967-018-1566-8.
MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
Zhao Y, Ma K, Yang S, Zhang X, Wang F, Zhang X
Int J Oncol. 2018; 53(2):644-658.
PMID: 29767234
PMC: 6017156.
DOI: 10.3892/ijo.2018.4409.
Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
Luo J, Shi K, Yin S, Tang R, Chen W, Huang L
World J Surg Oncol. 2018; 16(1):76.
PMID: 29636077
PMC: 5894244.
DOI: 10.1186/s12957-018-1378-6.
Evaluation of altered expression of and as an early diagnostic approach in gastric cancer.
Shirmohammadi K, Sohrabi S, Jafarzadeh Samani Z, Effatpanah H, Yadegarazari R, Saidijam M
J Gastrointest Oncol. 2018; 9(1):46-51.
PMID: 29564170
PMC: 5848032.
DOI: 10.21037/jgo.2017.11.04.
Tumor suppressive role of miR-569 in lung cancer.
Ping Zheng Y, Wu L, Gao J, Wang Y
Oncol Lett. 2018; 15(4):4087-4092.
PMID: 29541173
PMC: 5835959.
DOI: 10.3892/ol.2018.7869.
The Na/Cl-Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis.
Sikder M, Yang S, Ganapathy V, Bhutia Y
AAPS J. 2017; 20(1):12.
PMID: 29204754
DOI: 10.1208/s12248-017-0164-7.
Infrequently expressed miRNAs influence survival after diagnosis with colorectal cancer.
Slattery M, Pellatt A, Lee F, Herrick J, Samowitz W, Stevens J
Oncotarget. 2017; 8(48):83845-83859.
PMID: 29137387
PMC: 5663559.
DOI: 10.18632/oncotarget.19863.
Identifying factors associated with the direction and significance of microRNA tumor-normal expression differences in colorectal cancer.
Stevens J, Herrick J, Wolff R, Slattery M
BMC Cancer. 2017; 17(1):707.
PMID: 29084506
PMC: 5663119.
DOI: 10.1186/s12885-017-3690-x.
miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating Promoter Activity and Can be Therapeutically Targeted to Inhibit Lung Metastases.
Yang Y, Huang G, Zhou Z, Fewell J, Kleinerman E
Mol Cancer Ther. 2017; 17(1):130-139.
PMID: 29079708
PMC: 5752589.
DOI: 10.1158/1535-7163.MCT-17-0042.
MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling.
Ma F, Li W, Liu C, Li W, Yu H, Lei B
Oncotarget. 2017; 8(41):69538-69550.
PMID: 29050223
PMC: 5642498.
DOI: 10.18632/oncotarget.18422.